Zdenek Vrozina Profile picture
Jul 28 14 tweets 3 min read Read on X
A new mouse study gives us a hard close-up of something long COVID data keeps hinting at.
SARS2 gets into the brain, clears out within a month - and the damage it leaves behind doesn’t just persist, it keeps growing. The virus clears out and leaves scorched earth behind it🧵
K18-hACE2 mice, Delta, tracked at 6/14/30 days post infection.
Day 6 - virus peaks in the brain (both N-protein and infectious particles).
Day 14 - only half the animals still have it.
Day 30 - undetectable.
The classic pattern - acute neuroinvasion, then cleanup.
This K18 model inflates the magnitude of the neurological hit.
But what doesn’t rest on the inflation is the shape of the finding - and that’s the part that matters.
Pericytes (the cells that hold the blood-brain barrier together) start dying off across the brain, from day 14 onward. And they’re not dying because the virus infected them. No N-protein in pericytes at any stage. What kills them is the inflammation around them, not a direct hit.
It uncouples the damage from direct infection. You don’t need virus inside the cell. You just need the environment it sets off around itself.
TNF-α and IFN-γ - the cytokines driving that death - stay elevated out to day 30. Long after the virus is cleared.
The fire feeds itself. Virus gone, inflammation still burning, pericytes falling, barrier opening up.
Fibrin starts leaking into the brain. Claudin-5 (a barrier-sealing protein) drops. Neurons in the hippocampus thin out.
In parallel, Alzheimers-linked genes come online - APP, BACE1, PSEN1, MAPT (tau) - and β-amyloid (Aβ1–42) accumulates and stays up through day 30.
Aβ rises earlier (day 6) than its own precursor protein APP, which only climbs significantly by day 30. The authors read this through the hypothesis that Aβ starts as an antimicrobial defense.
Dementia/tauopathy are a machine prediction off a gene list.
30 days is not a human long-COVID timeline. Whatever these mice showed by day 30, the human version of that window isn’t days - it’s a much longer stretch we mostly haven’t watched. Months at least.
Add the symmetry that survivorship demands. Only animals that survived the acute - largely lethal - phase were analyzed. The worst-hit brains weren’t around to be scanned. The scorched ground we can see is more likely underestimated than inflated.
Why this is worth attention beyond the mouse cage? It lines up with Duffs human finding 2025, plasma evidence of increased β-amyloid pathology after SARS2. The mouse mechanism (pericytes - barrier - inflammation - amyloid) and the human plasma signal point the same way.
History knows this script. The 1918 flu - encephalitis lethargica - parkinsonism years after the acute infection. HIV and HAND damage smoldering below the clinical line once the acute phase passes. The virus leaves first, the disease shows up last.
Which is why I recovered, my tests are negative isn’t the end of the story - it may be the start of it. The virus leaves scorched earth behind it, quietly, with no acute signal to warn you - and across repeat infections, it adds up.
Too much signal now to keep operating without prevention. @szupraha @ZdravkoOnline @adamvojtech86
Lawal at al., Neuroinflammation, Pericyte Dysfunction, and Alzheimer’s Disease-Associated Gene Expression and Pathway Activation in the Brain of SARS-CoV-2-Infected Mice. mdpi.com/1999-4915/18/7…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Zdenek Vrozina

Zdenek Vrozina Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ZdenekVrozina

Jul 28
Two variants that went on to dominate the world - BA.2.86 and its descendant JN.1 - replicate worse in the airways than the variant they displaced.
But better in the small intestine.
New work from HKU shows viral fitness isn’t a single number - it’s a trade off between tissues.🧵
We each carry a different mix of past infections and vacc. That immune background masks what a variant can intrinsically do. The authors got around it by testing replication in tissue models with no immune system - where only the virus’s own biology shows through.
Four models. Ex vivo explants of human bronchus and lung, airway organoids, proximal intestinal enteroids duodenum, the start of the small intestine, and Caco-2, a tumour cell line standing in for the large intestine. Six variants, from WT to JN.1.
Read 17 tweets
Jul 26
COVID & amyloid.
Since 2022, a growing body of research has taken one possibility seriously - that amyloid - proteins refolded into clumped, degradation resistant aggregates plays a role in the pathology of COVID/long COVID. This isn't a fringe idea. At least five independent labs stand behind it, plus a review in Lancet Neurology.🧵
Two 2022 papers laid the groundwork. Nyström & Hammarström found seven amyloidogenic segments within the spike protein. Charnley identified peptides from SARS2 that self-assemble into structures toxic to neurons. Both cleared the formal bar - the dye ThT, Congo red with birefringence, and fibrils under the microscope. That's the threshold the field sets for calling something amyloid.
Since then, follow ups have accumulated across groups. Larsson 2023, cross-seeding with prion and Aβ, Sanislav 2024, polymorphs and neurotoxicity, the Hansmann branch α-synuclein, Aβ, and Follmer/Gemignani, α-synuclein and Parkinson's. The signal converges from several independent directions.
Read 23 tweets
Jul 22
Interferon works against SARS2. In these experiments it knocks infection down by 80 to 96%.
But it doesn’t cut evenly. What it leaves standing is the spread that runs by a route it can’t reach.
A new NIAID paper shows what that did to spike evolution🧵
The virus has two options for getting into the neighbouring cell.
Package itself into a virion, swim out, enter again. Out there it’s exposed to everything waiting for it.
Or fuse the infected cell with its neighbours into one multinucleated cell - a syncytium - and never go outside at all.
Interferon induced defence proteins mostly target the first route. Entry of an incoming virion.
A membrane fusing between two cells isn’t an incoming virion.
One route gets choked hard, the other much less.
Read 18 tweets
Jul 13
SARS2 doesn’t have to infect the brain to damage it. A new review in Frontiers Neurol. lays out how - and builds the whole thing on a cell long COVID coverage almost never mentions.
The mast cells in your meninges.🧵
Most post-mortem brains don’t show the virus productively infecting neurons or microglia. So where’s the damage coming from? The answer the review builds toward - it isn’t replicating virus driving this. It’s spike protein that stays behind.
The most solid, independent part of the review story? Swank 2023. Full-length spike in the plasma of 60% of people with PASC, up to 17 months out - nothing in acute patients in week one. Peluso 2024. Persistence past 14 months, with levels tracking markers of immune activation.
Read 16 tweets
Jul 13
New interesting mouse study out of Barcelona follows K18-hACE2 mice for 60 days after SARS2 infection. The trick - a deliberately low dose, so most animals survive the acute phase and can actually be followed this long. The goal - catch what’s left once acute COVID clears🧵
They recovered from mild COVID. Two (mouse) months later - nothing in the blood, but persistent immune dysregulation in tissue and a shrunken vagus nerve. A standard blood draw would’ve sent them home healthy.
At the group level, infected and control animals didn’t differ on behavior. At all. The signal only shows up in individual z-scores - a subset of animals carries the damage while the rest look normal. It’s not all the mice got worse, it’s some got notably worse.
Read 17 tweets
Jul 11
A Toronto group took the same brain scan used to track Parkinsons - and pointed it at people with long COVID.
Dopamine nerve terminals in the striatum - reduced. Down in the range you’d see in mild-to-moderate Parkinson’s. Lancet family.🧵
The scan is DTBZ PET. It measures VMAT2 - the density of dopamine neuron terminals across three parts of the striatum. One for motivation, one for movement, one for memory.
This is an established Parkinson’s tool. Not something rigged up for COVID.
24 people with long COVID, 24 age matched healthy controls. Lower signal in all three regions. Magnitude comparable to mild-to-moderate PD - and the putamen sits at the level you see in RBD (REM sleep behaviour disorder, most specific early precursor to synucleinopathy). @DavidJoffe64_2
Read 16 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(